Topical epidermal growth factor (EGF) may be effective in the treatment of patients with diabetic foot ulcer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1515, 2005-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical application of nerve growth factor may be an effective therapy for pressure ulcers

Inpharma, Vol. 1, Iss. 1415, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Gefitinib is an effective treatment for patients with non-small-cell lung cancer (NSCLC) and mutations in the epidermal growth factor receptor

Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

The Diabetic Foot Ulcer Scale-Short Form (DFS-SF) comprehensively measures the impact of diabetic foot ulcers on patients' QOL

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 440, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Topical tacrolimus may be effective in paediatric patients with severe treatment-resistant Crohn's disease

Inpharma, Vol. 1, Iss. 1255, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Recent Advances in Polymer-based Wound Dressings for the Treatment of Diabetic Foot Ulcer: An Overview of State-of-the-art

Current Drug Targets, Vol. 19, Iss. 5, 2018-03 ,pp. : 527-550

Bentham Science Publishers

Access to resources Recommend Favorite